儿童及青少年横纹肌肉瘤诊疗规范(2019版)

2019-09-05 中华人民共和国国家卫生健康委员会 中华人民共和国国家卫生健康委员会官网

横纹肌肉瘤(rhabdomyosarcoma,RMS)是儿童期最常见的软组织肿瘤,占儿童肿瘤的6.5%左右。其临床表现多样,异质性强,预后与肿瘤原发部位、大小、压迫及侵犯周围组织、器官程度以及病理类型有关。原发部位以头颈部及泌尿生殖系统最常见,其次为四肢、躯干等其余部位。RMS 对化疗、放疗敏感,但单一治疗效果差,需要肿瘤内、外科、放疗等多学科联合的综合治疗。儿童横纹肌肉瘤研究(美国)协作组(In

中文标题:

儿童及青少年横纹肌肉瘤诊疗规范(2019版)

发布日期:

2019-09-05

简要介绍:

横纹肌肉瘤(rhabdomyosarcoma,RMS)是儿童期最常见的软组织肿瘤,占儿童肿瘤的6.5%左右。其临床表现多样,异质性强,预后与肿瘤原发部位、大小、压迫及侵犯周围组织、器官程度以及病理类型有关。原发部位以头颈部及泌尿生殖系统最常见,其次为四肢、躯干等其余部位。RMS 对化疗、放疗敏感,但单一治疗效果差,需要肿瘤内、外科、放疗等多学科联合的综合治疗。儿童横纹肌肉瘤研究(美国)协作组(Intergroup RMS Study Group,IRSG)和儿童软组织肉瘤研究(欧洲)协作组(European Pediatric soft tissue sarcomas study group,EpSSG)等较大儿童肿瘤研究组经过20 余年的临床研究,并根据病理亚型、术后病理分期和 TNM 分期,将RMS 分为低危、中危和高危3 组,进行分层和综合治疗,不断优化治疗方案,进一步改善预后,使得RMS 疗效逐年提高。

 

拓展指南:横纹肌肉瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=儿童及青少年横纹肌肉瘤诊疗规范(2019版))] GetToolGuiderByIdResponse(projectId=1, id=0bbcf1c001e93657, title=儿童及青少年横纹肌肉瘤诊疗规范(2019版), enTitle=, guiderFrom=中华人民共和国国家卫生健康委员会官网, authorId=null, author=, summary=横纹肌肉瘤(rhabdomyosarcoma,RMS)是儿童期最常见的软组织肿瘤,占儿童肿瘤的6.5%左右。其临床表现多样,异质性强,预后与肿瘤原发部位、大小、压迫及侵犯周围组织、器官程度以及病理类型有关。原发部位以头颈部及泌尿生殖系统最常见,其次为四肢、躯干等其余部位。RMS 对化疗、放疗敏感,但单一治疗效果差,需要肿瘤内、外科、放疗等多学科联合的综合治疗。儿童横纹肌肉瘤研究(美国)协作组(In, cover=, journalId=null, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Sep 05 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>横纹肌肉瘤(rhabdomyosarcoma,RMS)是儿童期最常见的软组织肿瘤,占儿童肿瘤的6.5%左右。其临床表现多样,异质性强,预后与肿瘤原发部位、大小、压迫及侵犯周围组织、器官程度以及病理类型有关。原发部位以头颈部及泌尿生殖系统最常见,其次为四肢、躯干等其余部位。RMS 对化疗、放疗敏感,但单一治疗效果差,需要肿瘤内、外科、放疗等多学科联合的综合治疗。儿童横纹肌肉瘤研究(美国)协作组(Intergroup RMS Study Group,IRSG)和儿童软组织肉瘤研究(欧洲)协作组(European Pediatric soft tissue sarcomas study group,EpSSG)等较大儿童肿瘤研究组经过20 余年的临床研究,并根据病理亚型、术后病理分期和 TNM 分期,将RMS 分为低危、中危和高危3 组,进行分层和综合治疗,不断优化治疗方案,进一步改善预后,使得RMS 疗效逐年提高。</P> <P> </P>拓展指南:<strong>与<font color=red>横纹肌肉瘤</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=e6f051c001e9355c" title="儿童及青少年非横纹肌肉瘤类软组织肉瘤诊疗规范(2019版)" target=_blank>儿童及青少年非横纹肌肉瘤类软组织肉瘤诊疗规范(2019版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=35cda1c001513040" title="中国儿童及青少年横纹肌肉瘤诊疗建议(CCCG-RMS-2016)" target=_blank>中国儿童及青少年横纹肌肉瘤诊疗建议(CCCG-RMS-2016)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E6%A8%AA%E7%BA%B9%E8%82%8C%E8%82%89%E7%98%A4" target=_blank>有关横纹肌肉瘤更多指南</a></ul>, tagList=[TagDto(tagId=15167, tagName=横纹肌肉瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14582, appHits=392, showAppHits=9, pcHits=11390, showPcHits=4391, likes=67, shares=24, comments=6, approvalStatus=1, publishedTime=Sun Sep 22 22:14:59 CST 2019, publishedTimeString=2019-09-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Sep 22 22:14:59 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 03:14:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=儿童及青少年横纹肌肉瘤诊疗规范(2019版))])
儿童及青少年横纹肌肉瘤诊疗规范(2019版)
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241870, encodeId=649e12418e032, content=有没有更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e31946314, createdName=梦荷, createdTime=Mon Aug 29 17:34:37 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188474, encodeId=901011884e403, content=指导临床规范治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f231885199, createdName=ms1480598562844655, createdTime=Thu Jan 27 00:11:35 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913855, encodeId=d171913855df, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6e45439943, createdName=ms7000000599531802, createdTime=Tue Jan 05 11:55:13 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896476, encodeId=338e8964e68b, content=很好,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f15d3890604, createdName=1381d648m98暂无昵称, createdTime=Tue Nov 03 07:56:57 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894003, encodeId=c1488940035f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/ce079fd0944b4af0896c4bdb2d547ac3/73f2f6c2202b43ceb43dd2354f7f73e6.jpg, createdBy=dfab5426678, createdName=ms2000001622015603, createdTime=Fri Oct 23 20:25:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2022-08-29 梦荷

    有没有更新

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1241870, encodeId=649e12418e032, content=有没有更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e31946314, createdName=梦荷, createdTime=Mon Aug 29 17:34:37 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188474, encodeId=901011884e403, content=指导临床规范治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f231885199, createdName=ms1480598562844655, createdTime=Thu Jan 27 00:11:35 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913855, encodeId=d171913855df, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6e45439943, createdName=ms7000000599531802, createdTime=Tue Jan 05 11:55:13 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896476, encodeId=338e8964e68b, content=很好,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f15d3890604, createdName=1381d648m98暂无昵称, createdTime=Tue Nov 03 07:56:57 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894003, encodeId=c1488940035f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/ce079fd0944b4af0896c4bdb2d547ac3/73f2f6c2202b43ceb43dd2354f7f73e6.jpg, createdBy=dfab5426678, createdName=ms2000001622015603, createdTime=Fri Oct 23 20:25:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2022-01-27 ms1480598562844655

    指导临床规范治疗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1241870, encodeId=649e12418e032, content=有没有更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e31946314, createdName=梦荷, createdTime=Mon Aug 29 17:34:37 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188474, encodeId=901011884e403, content=指导临床规范治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f231885199, createdName=ms1480598562844655, createdTime=Thu Jan 27 00:11:35 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913855, encodeId=d171913855df, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6e45439943, createdName=ms7000000599531802, createdTime=Tue Jan 05 11:55:13 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896476, encodeId=338e8964e68b, content=很好,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f15d3890604, createdName=1381d648m98暂无昵称, createdTime=Tue Nov 03 07:56:57 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894003, encodeId=c1488940035f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/ce079fd0944b4af0896c4bdb2d547ac3/73f2f6c2202b43ceb43dd2354f7f73e6.jpg, createdBy=dfab5426678, createdName=ms2000001622015603, createdTime=Fri Oct 23 20:25:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2021-01-05 ms7000000599531802

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1241870, encodeId=649e12418e032, content=有没有更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e31946314, createdName=梦荷, createdTime=Mon Aug 29 17:34:37 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188474, encodeId=901011884e403, content=指导临床规范治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f231885199, createdName=ms1480598562844655, createdTime=Thu Jan 27 00:11:35 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913855, encodeId=d171913855df, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6e45439943, createdName=ms7000000599531802, createdTime=Tue Jan 05 11:55:13 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896476, encodeId=338e8964e68b, content=很好,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f15d3890604, createdName=1381d648m98暂无昵称, createdTime=Tue Nov 03 07:56:57 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894003, encodeId=c1488940035f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/ce079fd0944b4af0896c4bdb2d547ac3/73f2f6c2202b43ceb43dd2354f7f73e6.jpg, createdBy=dfab5426678, createdName=ms2000001622015603, createdTime=Fri Oct 23 20:25:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-11-03 1381d648m98暂无昵称

    很好,学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1241870, encodeId=649e12418e032, content=有没有更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e31946314, createdName=梦荷, createdTime=Mon Aug 29 17:34:37 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188474, encodeId=901011884e403, content=指导临床规范治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f231885199, createdName=ms1480598562844655, createdTime=Thu Jan 27 00:11:35 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913855, encodeId=d171913855df, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6e45439943, createdName=ms7000000599531802, createdTime=Tue Jan 05 11:55:13 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896476, encodeId=338e8964e68b, content=很好,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f15d3890604, createdName=1381d648m98暂无昵称, createdTime=Tue Nov 03 07:56:57 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894003, encodeId=c1488940035f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/ce079fd0944b4af0896c4bdb2d547ac3/73f2f6c2202b43ceb43dd2354f7f73e6.jpg, createdBy=dfab5426678, createdName=ms2000001622015603, createdTime=Fri Oct 23 20:25:32 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-23 ms2000001622015603

    学习

    0